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ABSTRACT 
 
Ascorbate peroxidase (APX) is a class I heme peroxidase. It has two sites for binding of 
substrates. One is close to the -heme edge and is used for oxidation of ascorbate; the 
other is at the -heme edge and is used for binding of aromatic substrates [Gumiero et al, 
(2010) Arch. Biochem. Biophys. 500, 13-20]. In this work, we have examined the structural 
factors that control binding at the -heme edge by replacement of Ala134 in APX with a 
proline residue that is more commonly found in other class II and III peroxidases. Kinetic 
data indicate that replacement of Ala134 by proline has only a small effect on the catalytic 
mechanism, or the oxidation of ascorbate or guaiacol. Chemical modification with 
phenylhydrazine indicates that heme accessibility close to the -heme edge is only minorly 
affected by the substitution. We conclude that the A134P mutation alone is not enough to 
substantially affect the reactivity of APX towards aromatic substrates bound at the -heme 
edge.  The data are relevant to the recent application of APX (APEX) in cellular imaging.   
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INTRODUCTION 
Heme peroxidases catalyse the H2O2-dependent oxidation of a wide variety of substrates. 
The family of heme peroxidases share a common mechanism of oxidation which involves 
the formation of high-valent Compound I and Compound II intermediates [1]. These 
intermediates have been extensively studied in numerous peroxidase systems ever since 
the identification of these species in the 1950s [2, 3]. In contrast, it has taken much longer 
to understand the factors that control peroxidase substrate specificity. This was in part 
because the substrate specificity of peroxidase enzymes is very diverse but also because 
the actual physiological substrate is often difficult to identify. Most peroxidases are 
believed to oxidise small organic (usually phenolic) substrates under physiological 
conditions but there are prominent exceptions, notably cytochrome c peroxidase (CcP) 
and ascorbate peroxidase (APX) which use cytochrome c and ascorbate as their 
substrates, respectively. Many peroxidases will oxidise different kinds of substrate, 
probably at different locations [reviewed in [4]]. Initial predictions from chemical 
modification experiments [5-7] and from NMR (reviewed in [8, 9]) that substrates 
interacted with the heme at the -heme edge were later proved correct as crystal 
structures emerged for a number of substrate-bound complexes [4]. But the picture 
became more complex as a number of peroxidases – notably ascorbate peroxidase [10] 
and manganese peroxidase [11] – bind some substrates at the -heme edge instead.  
In the case of ascorbate peroxidase (APX), we have established that there are two main 
sites for substrate oxidation. The first, close to the -heme edge, is used by ascorbate 
and is presumed to be the main physiological binding site [10, 12], Figure 1A. There is 
another binding site, close to the -heme edge [13], which is similar to that used in 
horseradish [14] and other [15, 16] peroxidases for closely related substrates. The -
heme edge is widely regarded as the main site of oxidation for phenolic substrates (such 
as guaiacol) that are commonly used in peroxidase assays, but there is no direct 
structural evidence for binding of guaiacol at the -heme edge in any heme peroxidase 
and in CcP it is known that guaiacol binds at other locations [17]. The -heme edge is 
exposed to solvent in APX; Ala134 is also exposed to solvent and lies adjacent to the -
meso position, Figure 1B (4.4 Å from -meso to C of Ala134). The residue equivalent to 
Ala134 in APX is also present in CcP (Ala147) but is replaced with a proline in other class 
II and III peroxidases [18, 19], Figure 1C. To examine the role of Ala134 in controlling 
peroxidase reactivity at the -heme edge, we prepared a variant of APX in which Ala134 
has been replaced with a proline and have examined the effect of this mutation on the 
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substrate specificity. This is relevant to the recent application of APX [20], and its A134P 
variant [21], in cellular imaging.  
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EXPERIMENTAL 
 
Site-directed mutagenesis was performed according to the QuikChange™ protocol 
(Stratagene), using a wild-type pea cytosolic APX-encoding pMAL-c2 vector. Sequences 
for the forward and reverse oligonucleotides were 
5’(CGCTTGCCTGATCCGACTAAGGGTTCTG)3’ and 
3’(GCGAACGGACTAGGCTGATTCCCAAGAC)5’ respectively, with the 5' end 
phosphorylated and the bases underlined indicating the mutation site. Sequencing across 
the whole gene confirmed the presence of the required codon and the absence of other 
mutations. No alterations to published protocols [22] were required to successfully isolate 
A134P in moderate yields and with acceptably high purity (RZ > 1.7). An absorption 
coefficient of 404 = 92 mM
-1cm-1 for A134P, obtained using the pyridine hemochromagen 
method [23], was used to calculate enzyme concentrations. 
Binding constants for binding of anionic ligands to the heme were determined according to 
previous protocols [24].  
Steady state (pH 7.0, 25.0 oC) data were collected as previously reported [12] and were 
fitted either to the Michaelis-Menten equation or to the Hill equation (v = Vmax [S]
n/(Kn + [S]n), 
where v is the initial rate, n is a qualitative indication of the level of cooperativity, K is the 
substrate concentration at which the velocity is half-maximal, and Vmax is the maximum 
velocity. When n = 1, the Hill equation reduces to the more usual Michaelis-Menten 
equation (v = Vmax / (1 + KM/[S])).  
Pre-steady state (pH 7.0, 5.0 oC) kinetic experiments were carried out according to 
published protocols [24]. Compound I and Compound II spectra were obtained by addition 
of a 1:1 and 10:1 ratio of hydrogen peroxide to wild-type APX respectively. Second order 
rate constants for Compound I, k1, and Compound II, k2, formation were obtained as 
previously [24]; Compound II reduction was measured at 420 nm (Compound I/Compound 
II isosbestic point) after pre-formation of Compound I.  
Phenylhydrazine modification was carried out by reacting the enzyme in the presence of 
the suicide substrate according to published protocols [22]; modification was complete 
within 1 minute in both cases. The extent of enzyme inactivation was measured by 
assaying with L-ascorbate, guaiacol and 2,2’-azinobis-3-ethylbenzothiazoline-6-sulphonic 
acid according to published protocols [22]. Heme was extracted from inactivated enzyme 
as described previously and re-dissolved in a minimal volume (<100 l) of the HPLC elution 
buffer. High performance liquid chromatographic analysis was carried out using a 5 m 
Hypercil BDS C-18 column (4.6 mm x 250 mm, Thermoquest) with a computer-controlled 
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ProStar HPLC apparatus (Varian) and an isocratic acetonitrile/water/trifluoroacetic acid 
elution buffer (50:50:0.1 v/v). 
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RESULTS 
 
Characterisation of A134P. The electronic absorption spectra of A134P has a Soret band 
that is slightly red-shifted (max = 404 nm) relative to the wild type (max = 403 nm [22]). 
Wavelength maxima for various ligand-bound complexes of ferric A134P, Table 1, are 
similar to the equivalent species in the wild type enzyme. These spectra are consistent 
with the replacement of a residue that is remote from the heme iron which would not be 
expected to substantially perturb the properties of the heme group. The dissociation 
constants, KD, for binding of cyanide (KD,cyanide = 0.6  0.1 M) and azide (KD, azide = 235  59 
M) to the heme were also not significantly different from the wild type (KD,cyanide = 1.2  0.3 
M; KD,azide = 300  75 M).  
Pre-steady state kinetics. The Compound I intermediate of A134P forms normally (Figure 
2, Table 1) and is consistent with a porphyrin -cation radical formulation as has been 
established for the wild type protein [24]. Observed pseudo-first order rate constants (k1,obs 
) for Compound I formation in A134P (data not shown) showed a linear dependence on 
H2O2 concentration in the range 0 - 15 M H2O2 (k1 = 5.1 ± 0.2 x 10
7 M-1 s-1 compared to k1 
= 6.1 x 107 M-1s-1 for wild type [24]). Wavelength maxima for Compound II of A134P, Figure 
2, Table 1, are also in agreement with those for the wild enzyme [27]). Rate constants, 
k2,obs, for reduction of Compound I to Compound II (data not shown) were linearly dependent 
on L-ascorbic acid concentration (k2 = 2.9 ± 0.1 x 10
7 M-1s-1 compared to k2 = 2.7 x 10
7 M-1s-1 
for wild type [24]). Reduction of Compound II showed saturation kinetics between 0 and 
500 µM L-ascorbic acid (HS in equation [1] below), consistent with the following 
mechanism, equations [1] and [2]: 
 
Compound II + HS 
𝐾𝑎
⇔  [Compound II-HS]        … [1] 
[Compound II + HS] 
𝑘3
→  FeIII +  S•     … [2] 
 
and an expression for k3,obs  can be derived, equation [3] where [HS] is the concentration of 
ascorbate and Kd is the equilibrium dissociation constant for the substrate-bound complex 
(Kd = 1/Ka).  
 
𝑘3,obs =  
𝑘3
1 +  𝐾d [HS]⁄
     … [3] 
 
7 
 
 7 
A non-linear fit of the data to equation [3], Figure 3, yielded k3 = 79 ± 5 s
-1 and Kd = 610 ± 
100 M for A134P (k3 = 73 s
-1and Kd = 560 M for wild type).  
These data show that the rate constants in the peroxidase reaction mechanism are not 
significantly affected by the replacement of A134 by proline.  
Steady state kinetics – oxidation of ascorbate and guaiacol. The steady-state oxidation of 
ascorbate by APX does not obey simple Michaelis-Menten kinetics, and a sigmoidal 
dependence of rate on substrate concentration is observed [25]. The A134P variant 
behaves similarly and plots of initial rate (µM s-1) versus L-ascorbic acid concentration show 
a non-hyperbolic response, Figure 4. Steady state constants are given in Table 2. In 
contrast, oxidation of guaiacol by A134P exhibited conventional Michaelis-Menten type 
kinetics (data not shown); values for kcat , KM and kcat /KM, are given in Table 2 and are 
essentially as for the wild type protein.  
Chemical modification – Phenylhydrazine modification of horseradish leads to the 
formation of both  -mesophenyl and 8-hydroxymethyl heme derivatives [5, 6]. The method 
involves the formation of a phenyl radical through the oxidation of phenylhydrazine during 
peroxidase turnover with peroxide, and the product distributions have been interpreted as 
evidence that aromatic substrates interact at the exposed -position of the heme. 
Phenylhydrazine modification of APX has been shown [22] to produce the same  -
mesophenyl and 8-hydroxymethyl heme products, although higher proportions of -
mesophenyl heme are observed compared to HRP. In Figure 5 are shown the HPLC traces 
of the heme-derived components extracted from phenylhydrazine-modified wild type APX 
and A134P. The data for A134P indicate that the product distribution is similar to that of 
wild type APX and is dominated by formation of the -mesophenyl heme (Figure 5). In 
HRP, which also contains a proline (Pro141) at the equivalent position, lower relative 
amounts of -mesophenyl heme are observed compared to the 8-hydroxymethyl product, 
but we do not interpret those differences as meaningful in terms of overall reactivity. The 
main points to note here are: (i) that both APX and HRP show the same modified products, 
consistent with substrate interactions at the -heme edge, and (ii) that the insertion of a 
proline does not substantially alter the product distribution in APX (see Discussion).  
Attempts to decrease heme accessibility through introduction of a Phe residue at 
position134 were unsuccessful because the A134F variant was isolated as the apo-form 
from E. coli and reconstitution protocols with exogenous heme did not generate catalytically 
active enzyme in our hands.  
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DISCUSSION 
There is only one crystal structure for a peroxidase (CcP) in complex with guaiacol [17], 
and this shows that guaiacol is bound at two different locations, neither of which are close 
to the -meso edge. However, inhibition data and mutagenesis [17] strongly suggest that 
the catalytic binding site for aromatic compounds can occur the -heme edge in CcP. The 
observation that binding of guaiacol is relatively nonspecific (and of low affinity) is 
consistent with the widespread activity of all peroxidase enzymes for guaiacol. It is likely, 
therefore, that APX also contains multiple (non-specific) binding site for phenolic molecules 
in addition to a binding site close to the -heme edge.  
We sought to probe the reactivity at this -heme edge, and to make comparisons with 
other peroxidases. Our data show that the oxidation of ascorbate is largely unaffected by 
the A134P mutation, which is consistent with ascorbate binding close to the -heme edge 
[10]. Oxidation of guaiacol was also not substantially altered in the A134P variant. The 
chemical modification experiments demonstrate that introduction of a proline in APX does 
not substantially change the product distribution compared to wild type [22]. Our conclusion 
is that the introduction of a proline in A134P does not affect accessibility of the -meso 
position of the heme and does not affect reactivity of the enzyme towards guaiacol. By 
comparison with CcP above, it is likely that guaiacol oxidation in the A134P variant occurs 
from a number of binding sites – this would explain the steady state data (which are 
unaffected by the mutation) and would be in agreement with previous structural work on 
CcP [26] which shows that access to the heme is hindered in the A147Y and A147M 
variants while guaiacol activity is not greatly affected. 
These data are relevant to the recent application of APX [20], and its A134P variant [21], 
in cellular imaging using electron microscopy (EM). The EM method uses the intrinsic 
activity of APX towards aromatic substrates (diaminobenzidine in this case). The A134P 
variant of APX is observed [21] as a more sensitive reporter in cells than the wild type 
protein and this has been attributed to an increased stability of the A134P variant to 
peroxide-induced inactivation (although we note that inactivation by phenoxyl radical 
attack [27] might also be possible). We have not assessed the mechanisms of inactivation 
in this work, but our data demonstrate that the A134P mutation alone does not affect the 
reactivity of APX towards aromatic substrates bound at the -meso position and thus 
would not account for the enhanced sensitivity of A134P in cellular imaging. Further 
enhancement of EM contrast through substantially enhanced aromatic substrate oxidation 
by APX will thus require more than a single mutation.  
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TABLE 1 
 
Wavelength maxima (nm) for various derivatives of wild type APX and A134P (pH 7.0, 25.0 
oC). sh denotes unresolved shoulder. 
 
 
Derivative Wild type A134P 
FeIII 403, 506, ~540sh, 636 404, 500, ~540sh, 636 
FeIII-CN- 419, 540, 572
sh 420, 540, 572sh 
FeIII-N3- 412, ~525, ~543, 569sh, 633 413, ~525, ~543, 569sh, 633 
Compound I 404, 529, 583sh, 650 406, 527, 584sh, 651 
Compound II 414, 528, 559 414, 530, 557 
   
   
 
TABLE 2 
 
Steady state kinetic parametersa (kcat, KM) and selectivity coefficients (kcat /KM) for the 
oxidation of L-ascorbic acid and guaiacol by rpAPX and A134P. 
 
 
  
 L-Ascorbic acid b Guaiacol 
 kcat  
(s-1) 
KM  
(µM) 
kcat/ KM  
(µM-1s-1) 
kcat 
(s-1) 
KM  
(mM) 
kcat/ KM  
(mM-1s-1) 
Wild type 248 ± 28 410 ± 40 0.61 66 ± 3b 12.3 ± 0.9 5.4 
A134P 264 ± 44 440 ± 40 0.60 91 ± 6 16.4 ± 0.7 5.6 
 
a 
All data were fitted using the Michaelis-Menten equation, except 
b 
where data were fitted using the Hill equation.  
b 
Data from reference [24]. 
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FIGURE LEGENDS 
 
Figure 1. (A) Left: The structure of the APX/ascorbate complex, showing the 
ascorbate bound through the heme 6-propionate and Arg172, and the location of 
Ala134 close to the -meso site. The - and -heme locations are indicated. Right: 
A slightly rotated view, showing only the ascorbate and the position of Ala134 in 
relation to the overall protein structure. (B) The protein surface in APX. Left: Viewed 
looking towards the -heme edge, showing the heme group (in white) exposed to 
solvent; the -meso carbon of the heme and A134 are highlighted in red. Right: 
Viewed looking towards the -heme edge, showing the heme 6-propionate (in red) 
exposed to solvent; ascorbate binds on the surface at this site, as shown in (A). (C) 
An alignment of the APX and HRP structures in the region of the -heme edge. The 
residues in HRP (Phe142, Pro141, Phe175) are labelled and are shown in pink; the 
corresponding APX residues (Asp133, Ala134, Thr135 and Phe175) are overlaid in 
green, with Ala134 indicated with a *.  
Figure 2. UV-visible absorption spectra of ferric A134P (solid line) and its oxidized 
Compound I (dotted line) and Compound II (dashed line) intermediates in the Soret 
(top) and visible (bottom, multiplied by a factor of 5) regions. Conditions: 2 M APX, 
5.0 °C, 0.1 M sodium phosphate pH 7.0. 
Figure 3. Pseudo-first-order rate constants, k3,obs, as a function of concentration of 
[L-ascorbic acid] for reduction of Compound II of wild-type APX (⚫) and A134P (). 
The solid lines in both cases are a fit of the data to equation [3]. Conditions: [APX]  
= 0.5 M, 5.0 °C, 0.1 M sodium phosphate pH 7.0. 
Figure 4. Steady-state oxidation of L-ascorbic acid by wild type (⚫) and A134P (). 
Data were fitted to the Hill equation (see methods). Conditions: [APX] = 25 nM, 
[H2O2] = 0.1 mM, 25.0 °C, 0.1 M sodium phosphate pH 7.0.  
Figure 5. Reverse-phase HPLC analyses of products derived from phenylhydrazine 
modification of wild type and A134P, monitored at 400 nm. Peaks corresponding to 
8-hydroxymethyl heme, unmodified heme and -mesophenyl heme are indicated. 
Peaks were assigned according to previously [22].  
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The role of Ala134 in controlling substrate specificity in ascorbate peroxidase was explored. Replacement of Ala134 
by proline has a small effect on oxidation of ascorbate or guaiacol. We conclude that the A134P mutation alone does 
not substantially affect the reactivity of towards aromatic substrates bound at the -heme edge.  
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